AdCella has made two new appointments to its clinical advisory board:

• Prof Nick Pavlakis, medical oncologist at Royal North Shore Hospital, Sydney, who specialises in thoracic and gastro-intestinal cancers and has been involved in writing treatment guidelines for mesothelioma

• Prof Mark Shackleton, Director of Oncology in the Alfred Care Group, Melbourne, whose research interests include precision oncology and immunotherapy

In addition to their deep domain expertise, AdCella's advisory board now represents five major hospitals involved in routine delivery of commercial CAR-T cell therapies that could become clinical trial sites for BZDS1901. The other members of the advisory board (announced previously) are:

• A/Prof Emily Blyth, Westmead Hospital, Sydney

• Prof Simon Harrison, Peter MacCallum Cancer Centre, Melbourne

• Prof Ben Solomon, Peter MacCallum Cancer Centre, Melbourne

• A/Prof Ben Tran, Peter MacCallum Cancer Centre and Epworth Hospital, Melbourne